Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Harry Porterfield to Child

This is a "connection" page, showing publications Harry Porterfield has written about Child.

 
Connection Strength
 
 
 
0.027
 
  1. Hoover AC, Segal RS, Zimmerman MB, Lee-Son K, Porterfield HS, Stewart SA, Rysavy MA. Urine Trouble: Reducing Midstream Clean Catch Urine Contamination Among Children 3-17 Years Old. Pediatrics. 2021 08; 148(2).
    View in: PubMed
    Score: 0.010
  2. Singh SB, McLearn-Montz AJ, Milavetz F, Gates LK, Fox C, Murry LT, Sabus A, Porterfield HS, Fischer AJ. Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor. Pediatr Pulmonol. 2019 08; 54(8):1200-1208.
    View in: PubMed
    Score: 0.009
  3. McDermott RA, Porterfield HS, El Mezayen R, Burks AW, Pons L, Schlichting DG, Solomon B, Redzic JS, Harbeck RJ, Duncan MW, Hansen KC, Dreskin SC. Contribution of Ara h 2 to peanut-specific, immunoglobulin E-mediated, cell activation. Clin Exp Allergy. 2007 May; 37(5):752-63.
    View in: PubMed
    Score: 0.004
  4. Palmer GW, Dibbern DA, Burks AW, Bannon GA, Bock SA, Porterfield HS, McDermott RA, Dreskin SC. Comparative potency of Ara h 1 and Ara h 2 in immunochemical and functional assays of allergenicity. Clin Immunol. 2005 Jun; 115(3):302-12.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)